ORTEXORTEX News
Tracking BSAC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
BS
Earnings PreviewBSAC

BSAC Heads Into Q3 Print With Shorts Building and Analysts Split

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 26 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

BSAC heads into its October 29 earnings release with short sellers quietly adding pressure and the stock already nursing a 10% loss over the past month.

The lending market tells a benign story for now. Borrow availability is ample at nearly 589% of short interest, meaning shares are plentiful for anyone wanting to establish or expand a short position. Cost to borrow sits at just 0.46%, barely changed on the week. What is moving is the short interest itself: shares short have climbed 12% over the past month and 6% in the past week alone, reaching roughly 840,000 shares. The ORTEX short score has edged up to 34.5, its highest in the 10-day window tracked here, a direction of travel worth watching even if the absolute level remains modest. The stock closed at $31.72 on October 23, down 3% on the week.

Options positioning has flipped sharply. The put/call ratio dropped to zero across the five sessions ending October 23, against a 20-day average of 1.13. That is nearly 1.7 standard deviations below the mean, a reading at the very bottom of the past year's range. After weeks of running at 1.5 or above, the sudden absence of puts may reflect a rotation out of downside hedges rather than genuine bullish conviction, particularly unusual just before a print.

The analyst debate is two-sided, and recent moves from bellwether names illustrate the divide clearly. JP Morgan cut its target to $39 from $43 on October 6, maintaining its Overweight rating, a signal that the bull case is intact but the firm sees less near-term runway. Goldman Sachs, which carries a Sell, lifted its target to $33 from $29 in July, acknowledging improvement even from the bearish side. The mean analyst target of around $35 sits above the current price, implying roughly 10% upside from here. Against that, the stock's price-to-book has compressed to 2.3x over the past month, and the earnings yield factor score ranks only in the 25th percentile, suggesting valuation is not an obvious draw for value-focused buyers.

One ownership angle is worth noting. Norges Bank Investment Management added 574 million shares in the quarter to June 30, a substantial build for a sovereign wealth fund. That contrasts with BTG Pactual Global Asset Management trimming its position as of September 30. Institutional ownership beyond the 67% parent-controlled Banco Santander stake remains fragmented, which means active manager flows can move the needle.

The October 29 print is therefore a test of whether BSAC's loan growth and net interest margin have held up through a quarter in which the stock has given back nearly a tenth of its value, and whether the recent build in short interest reflects a genuine deterioration in the earnings outlook or simply pre-event positioning.

Stocks in this article

See the live data behind this article on ORTEX.

Open BSAC on ORTEX →

How this article was generated

Generated
26 Oct 2026, 04:05
Data as of
26 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.